Literature DB >> 3531229

Immunoglobulin G subclasses of fluorescent anti-Treponema pallidum antibodies: evidence for sequential development of specific anti-T. pallidum immunoglobulin G responses in patients with early syphilis.

J J van der Sluis, E C van Reede, M Boer.   

Abstract

The development of immunoglobulin G (IgG) subclass-specific anti-Treponema pallidum antibodies during the course of syphilis in humans was studied with sera from 50 untreated male patients. The patients were divided into five diagnosis groups. In the fluorescent treponemal antibody test, which delineates the presence of cross-reacting antibodies, as well as specific antitreponema antibodies, IgG1, IgG2, and IgG3 subclass antibodies were already present during the seronegative primary stage. Specific antibodies, which were detected by the fluorescent treponemal antibody absorption test, were first present during the serotype-variable primary stage. These antibodies were almost exclusively of the IgG1 and IgG3 subclasses. In later stages, antibodies of other subclasses were detectable. Titration of IgG1 antitreponema antibodies in three electrophoretically different IgG fractions revealed an asymmetric distribution in these fractions during primary syphilis. The antibodies were largely confined to the most basic fraction during primary syphilis. A sudden change in the distribution was noted between the end of the primary stage and the secondary stage; an even distribution of IgG1 antitreponema antibodies existed in the late latent stage. These findings confirm and extend previous results from our laboratory. The development of antibodies detected by both tests is discussed in terms of a sequential stimulation of the immune system due to the presence of an extracellular layer covering the treponemas or, alternatively, in terms of a suppression of the immune response during early syphilis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531229      PMCID: PMC268926          DOI: 10.1128/jcm.24.3.418-423.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Protective layer covering pathogenic treponemata.

Authors:  S CHRISTIANSEN
Journal:  Lancet       Date:  1963-02-23       Impact factor: 79.321

2.  [Skin tests with purified Treponema pallidum-(TP) vaccine].

Authors:  K KIRALY; I RACZ
Journal:  Arch Klin Exp Dermatol       Date:  1960

3.  Study of the antigenic structure of Treponema pallidum by specific agglutination.

Authors:  P H HARDY; E E NELL
Journal:  Am J Hyg       Date:  1957-09

4.  Inoculation syphilis in human volunteers.

Authors:  H J MAGNUSON; E W THOMAS; S OLANSKY; B I KAPLAN; L DE MELLO; J C CUTLER
Journal:  Medicine (Baltimore)       Date:  1956-02       Impact factor: 1.889

5.  [Study on intradermal reaction to formol Treponema suspensions in syphilitics and normal subjects].

Authors:  J THIVOLET; A SIMERAY; M ROLLAND; F CHALLUT
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-07

6.  The quantification of human IgG subclasses in reference preparations.

Authors:  F Klein; F Skvaril; R Vermeeren; A Vlug; W J Duimel
Journal:  Clin Chim Acta       Date:  1985-08-15       Impact factor: 3.786

7.  Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test.

Authors:  A E von dem Borne; F M Helmerhorst; E F van Leeuwen; H G Pegels; E von Riesz; C P Engelfriet
Journal:  Br J Haematol       Date:  1980-06       Impact factor: 6.998

8.  Typing of subclasses and light chains of human monoclonal immunoglobulins by particle counting immunoassay (PACIA).

Authors:  C G Magnusson; D L Delacroix; J P Vaerman; P L Masson
Journal:  J Immunol Methods       Date:  1984-04-27       Impact factor: 2.303

9.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans.

Authors:  S A Baker-Zander; E W Hook; P Bonin; H H Handsfield; S A Lukehart
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

View more
  6 in total

1.  Anti-Treponema pallidum IgM, IgA, and IgG subclass antibody responses after treatment in patients with syphilis at various stages: 1. Assessments by enzyme-linked immunosorbent assay.

Authors:  S Tanaka; T Suzuki
Journal:  Genitourin Med       Date:  1990-06

2.  The inaccessibility of the outer membrane of adherent Treponema pallidum (Nichols strain) to anti-treponemal antibodies, a possible role of serum proteins.

Authors:  J J van der Sluis; M Kant; P C Onvlee; E Stolz
Journal:  Genitourin Med       Date:  1990-06

3.  The importance of different components of normal human serum and lysozyme in the rapid immobilisation of purified Treponema pallidum, Nichols strain.

Authors:  H J Engelkens; M Kant; P C Onvlee; E Stolz; J J van der Sluis
Journal:  Genitourin Med       Date:  1993-08

4.  Rapid in vitro immobilisation of purified Treponema pallidum (Nichols strain), and protection by extraction fluids from rabbit testes.

Authors:  H J Engelkens; M Kant; P C Onvlee; E Stolz; J J van der Sluis
Journal:  Genitourin Med       Date:  1990-10

5.  Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis.

Authors:  R E Baughn; J L Jorizzo; C B Adams; D M Musher
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

6.  The influence of different sera on the in vitro immobilisation of Percoll purified Treponema pallidum, Nichols strain.

Authors:  H J Engelkens; M Kant; P C Onvlee; E Stolz; J J van der Sluis
Journal:  Genitourin Med       Date:  1992-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.